CEO of GILYOS GmbH
After graduating in Pharmacology and receiving a PhD in Pharmaceutical Technology, Margit Gieseler started her professional career at Boehringer Ingelheim in Pharmaceutical Development.
She was initially responsible for the evaluation of new technologies and later for the development of formulas and processes for new early and late-phase active ingredients, including highly potent substances. She is also interested in continuous process improvement (Six Sigma).
She is author or co-author of the following chapter of GMP Compliance Adviser: